Published in Clin Res Hepatol Gastroenterol on June 01, 2011
Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C. J Clin Transl Hepatol (2014) 0.76
DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease. Clin Epigenetics (2016) 0.76
Early liver transplantation for severe alcoholic hepatitis. N Engl J Med (2011) 8.50
M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology (2013) 2.16
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach. Hepatology (2014) 2.05
Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA (2013) 1.94
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut (2010) 1.83
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration. Hepatology (2010) 1.82
Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis. J Hepatol (2011) 1.73
Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology (2009) 1.67
Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS One (2009) 1.25
Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis. Glycobiology (2005) 1.13
The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology (2006) 1.09
Comment on: "Management of alcohol dependence in patients with liver disease". CNS Drugs (2013) 1.07
NOD2: a potential target for regulating liver injury. Lab Invest (2008) 0.95
Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control. Gastroenterology (2009) 0.92
Evaluation of amantadine in chronic hepatitis C: a meta-analysis. J Hepatol (2004) 0.91
Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity. Eur J Gastroenterol Hepatol (2011) 0.89
Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease. Inflamm Bowel Dis (2009) 0.86
Peroxisome proliferator-activated receptors in HBV-related infection. PPAR Res (2009) 0.82
Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. Liver Transpl (2007) 0.81
Immunoglobulins are the major glycoproteins involved in the modifications of total serum N-glycome in cirrhotic patients. Proteomics Clin Appl (2010) 0.80
Treatment of severe forms of alcoholic hepatitis: where are we going? J Gastroenterol Hepatol (2008) 0.80
Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France. Hepatology (2009) 0.79
Drug-Eluting Beads Loaded With Doxorubicin (DEBDOX) Chemoembolisation Before Liver Transplantation for Hepatocellular Carcinoma: An Imaging/Histologic Correlation Study. Cardiovasc Intervent Radiol (2014) 0.77
Impact of viral eradication on mortality related to hepatitis C: a modeling approach in France. J Hepatol (2008) 0.76
Usefulness of viral kinetics for early prediction of a sustained virological response in HCV-1 non-responders re-treated with pegylated interferon and ribavirin. J Hepatol (2011) 0.75
Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision. J Clin Gastroenterol (2017) 0.75
[Acute recurrent pancreatitis in a composite CFTR heterozygote and Spink1 heterozygote patient]. Gastroenterol Clin Biol (2006) 0.75
Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision. J Clin Gastroenterol (2017) 0.75
[Therapeutic misadventure with acetaminophen in alcoholics]. Presse Med (2008) 0.75